Safety investigations for the bone regenerative medicine using growth factors secreted from the patients' own stem cells

Safety investigations for the bone regenerative medicine using growth factors secreted from the patients' own stem cells - Bone regeneration using the condition media from stem cells

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011286

Enrollment

Registered

2013-07-27

Start date

2011-09-29

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone defects due to removal of teeth, Periodontitis

Interventions

MSC-CM group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients after tooth extraction Patients who have periodontal pockets (over 4mm) after initial periodontal therapy

Exclusion criteria

Exclusion criteria: Patients who have contraindications for any surgery Patients who have bone metabolic disease such as osteoporosis, diabetes and neoplasms Patients who are treating with bisphosphonate or who have a history of treatment by BPs. Patients who are pregnancy, suspected pregnancy or breast-feeding

Design outcomes

Primary

Measure	Time frame
No complicatons and side effects will be seen 6 month after application	—

Countries

Japan

Contacts

Public ContactWataru Katagiri

Nagoya University Hospital Oral and Maxillofacial Surgery

w-kat@med.nagoya-u.ac.jp052-744-2348

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026

Safety investigations for the bone regenerative medicine using growth factors secreted from the patients&#39; own stem cells